In the pancreas, GLP1 receptor activation augments glucosedependent insulin secretion and suppresses inappropriate glucagon secretion, thereby improving postprandial glycemia without a high intrinsic risk of hypoglycemia in the absence of concomitant insulin or secretagogues
In this webinar, youll learn about benefits, side effects, real patient stories, and how our care team can support you every step of the way if you decide to give treatment a try
Mitochondrial fatty acid oxidation disorders: laboratory diagnosis, pathogenesis, and the complicated route to treatment
If youre a surgical bariatric patient on a GLP-1 medication, there are even more things to consider when it comes to your health and your goals
Stem Cell Research & Therapy , 11 (1), 182
Read our latest article where we ask the experts, Do Weight Loss Drugs Like Ozempic Hold The Answer to Long-Term Weight Management